EurekAlert!

Efficacy and safety of pleurodesis for lung cancer patients with interstitial lung disease

• Pleurodesis using talc or minocycline might be the treatment option against malignant pleural effusion (MPE) secondary to lung cancer with interstitial lung disease (ILD). What is known and what is ...
ascopubs.org

Efficacy and compliance of small-bore chest tube insertion and pleurodesis protocols for the treatment of malignant pleural effusions

Predictors of outcome and treatment decisions of older patients with stage III non-small cell lung cancer No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the ...
Healio

Indwelling pleural catheter for malignant pleural effusions reduces care costs

Please provide your email address to receive an email when new articles are posted on . The average health care cost per patient in the indwelling pleural catheter (IPC) group was $40,179 vs. $46,640 ...
ascopubs.org

A randomized phase II trial comparing carboplatin pleurodesis with cisplatin pleurodesis in patients with stage IIIB/IV non-small cell lung cancer (NSCLC) with malignant ...

Diagnostic strategy based on preoperative serum CEA levels in clinical stage IA NSCLC No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the 2006 ASCO Annual ...
Medscape

MesoVATS: Improved Symptoms, Not Survival, in Mesothelioma

SYDNEY — One of the few randomized phase 3 trials ever conducted in mesothelioma has found that keyhole surgery did not improve survival when compared with the standard treatment of talc pleurodesis.